LRMR.OQ - Larimar Therapeutics Inc
Guggenheim Securities LLC
LRMR - FY25 Recap; BLA Filing on Track for June 2026; BTD and Continued FDA Alignment Strengthens Our Confidence in Potential Approval; OLE Clinical Update in 2Q26
公司
LRMR.OQ
日期
2026-03-19
分析师
Mr. Yatin Suneja
页数
8 页
需要登录
请登录后购买研报或生成音频内容。